The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zabolotskikh I.B.

Kuban State Medical University

Belkin A.A.

Clinical Institute of Brain

Butrov A.V.

People’s Friendship University of Russia

Gorobets E.S.

N. N. Blokhin Russian Federationn Cancer Research Center under the Ministry of Health of the Russian Federation

Grigoriyev E.V.

Research Institute for Complex Issues of Cardiovascular Diseases

Kuzovlev A.N.

Federal Scientific and Clinical Center of Intensive Care and Rehabilitation

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Lubnin A.Yu.

Burdenko Neurosurgical Center

Muronov A.E.

Kuban State Medical University;
Regional Clinical Hospital No. 2

Ovezov A.M.

Moscow Regional Research and Clinical Institute

Ovechkin A.M.

Sechenov First Moscow State Medical University

Shadrin R.V.

SBIHC «Children’s Regional Clinical Hospital» of the Ministry of Healthcare of Kuban State of the Russian Federation

Shchegolev A.V.

Kirov Military Medical Academy

Perioperative management of patients with concomitant alcohol dependence. Guidelines

Authors:

Zabolotskikh I.B., Belkin A.A., Butrov A.V., Gorobets E.S., Grigoriyev E.V., Kuzovlev A.N., Lebedinskii K.M., Lubnin A.Yu., Muronov A.E., Ovezov A.M., Ovechkin A.M., Shadrin R.V., Shchegolev A.V.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2022;(4): 5‑25

DOI: 10.17116/anaesthesiology20220415

Views: 5307

Downloaded: 562

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Zabolotskikh IB, Belkin AA, Butrov AV, et al. . Perioperative management of patients with concomitant alcohol dependence. Guidelines. Russian Journal of Anesthesiology and Reanimatology. 2022;(4):5‑25. (In Russ.)
https://doi.org/10.17116/anaesthesiology20220415

Подписка 2025 (АиР)
МСФ на ЯМ
Close metadata
Recommended articles:
Anesthesia for adults in outpatient surgery. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):6-31
Epidemiology of acute poisoning in pediatric practice. Russian Journal of Anesthesiology and Reanimatology. 2024;(2):58-66
Intraoperative moni­toring of seda­tion and analgesia in patients over 70 years old in ENT surgery: a randomized prospective study. Russian Journal of Anesthesiology and Reanimatology. 2024;(4):24-31
Consciousness, sleep, anesthesia. What are we thinking about? Part I. Physiology of consciousness and sleep. Russian Journal of Anesthesiology and Reanimatology. 2024;(5):96-102
Qualitative and quantitative characteristics of stru­ctures of cere­bral cortex stru­cture in young people under conditions of chro­nic alco­hol into­xication. Fore­nsic Medi­cal Expe­rtise. 2024;(1):10-13
The role of anatomical study of the volume of the pterygomandibular space using sili­cone inje­ction as a predictor of safe anesthesia in the lower jaw. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(1):42-46
Anatomical features of the stru­cture of the mandibular retromolar triangle as a target point for local anesthesia in dentistry and maxi­llofacial surgery. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(2):51-58
Effi­cacy of inte­nsive therapy for massive intraoperative blood loss in children: expe­rience of the Moro­zov Hospital. Piro­gov Russian Journal of Surgery. 2024;(7):103-110
Impairment of executive functions in patients with alco­hol use diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):110-114
Clinical and dyna­mic features of alco­holism formation in middle-aged and elde­rly patients with primary orga­nic mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):73-78

Currently, alcohol is one of the most common psychoactive substances used in the Russian Federation and worldwide. According to WHO, about 140 million people on the planet suffer from alcohol addiction. As a result, patients with this diagnosis are encountered in clinical practice often and regularly, which makes it relevant to develop appropriate clinical guidelines. These guidelines reflect modern approaches to the management of patients with alcohol dependence, describe the principles of prevention and treatment of the most common complications, such as alcohol withdrawal syndrome, delirium tremens, infectious complications; the principles for assessing the risk of these conditions are also described.

Keywords:

alcoholism
alcohol dependence syndrome
alcohol delirium
perioperative period
anesthesia
intensive care
alcohol withdrawal syndrome

Authors:

Zabolotskikh I.B.

Kuban State Medical University

Belkin A.A.

Clinical Institute of Brain

Butrov A.V.

People’s Friendship University of Russia

Gorobets E.S.

N. N. Blokhin Russian Federationn Cancer Research Center under the Ministry of Health of the Russian Federation

Grigoriyev E.V.

Research Institute for Complex Issues of Cardiovascular Diseases

Kuzovlev A.N.

Federal Scientific and Clinical Center of Intensive Care and Rehabilitation

Lebedinskii K.M.

North-Western State Medical University n.a. Mechnikov, Federal Research;
Clinical Center of Intensive Care Medicine and Rehabilitology

Lubnin A.Yu.

Burdenko Neurosurgical Center

Muronov A.E.

Kuban State Medical University;
Regional Clinical Hospital No. 2

Ovezov A.M.

Moscow Regional Research and Clinical Institute

Ovechkin A.M.

Sechenov First Moscow State Medical University

Shadrin R.V.

SBIHC «Children’s Regional Clinical Hospital» of the Ministry of Healthcare of Kuban State of the Russian Federation

Shchegolev A.V.

Kirov Military Medical Academy

List of references:

  1. Schwartz A, Knez D. Anestesia and Alcohol Addiction. In: Bryson E.O., Frost E.A.M. Perioperative Addiction. Clinical Management of the Addicted Patient. Springer Science+Business Media, LLC. 2012;290. 
  2. Anohina IP. Basic biological mechanisms of dependence on psychoactive substances. In: Narkologija: nacional’noe rukovodstvo. Pod red. Ivanca N.N., Anohinoj I.P., Vinnikovoj M.A. M.: GEOTAR-Media; 2008. (In Russ.).
  3. Kirzhanova VV, Grigorova NI, Kirzhanov VN, Sidorjuk OV. Key performance indicators of the narcological office in the Russian Federation in 2014—2015: statistical compendium. FSBI «National Medical Research Center for Psychiatry and Narcology named after V.P. Serbsky» of the Ministry of Healthcare of the Russian Federation. M. 2016. (In Russ.).
  4. Koshkina EA, Kirzhanova VV. Epidemiology of drug addiction. In: Narkologija: nacional’noe rukovodstvo. Pod red. Ivanca N.N., Anohinoj I.P., Vinnikovoj M.A. M.: GEOTAR-Media; 2008. (In Russ.).
  5. Holt SR, Ramos J, Harma MA, et al. Prevalence of unhealthy substance use on teaching and hospitalist medical services: implications for education. Am J Addict. 2012;21(2):111-119.  https://doi.org/10.1111/j.1521-0391.2011.00207.x
  6. Smothers BA, Yahr HT, Ruhl CE. Detection of alcohol use disorders in general hospital admissions in the United States. Arch Intern Med. 2004;164(7):749-756.  https://doi.org/10.1001/archinte.164.7.749
  7. Saitz R, Freedner N, Palfai TP, Horton NJ, Samet JH. The severity of unhealthy alcohol use in hospitalized medical patients. The spectrum is narrow. J Gen Intern Med. 2006;21(4):381-385.  https://doi.org/10.1111/j.1525-1497.2006.00405.x
  8. Freyer-Adam J, Coder B, Baumeister SE, et al. Brief alcohol intervention for general hospital inpatients: a randomized controlled trial. Drug Alcohol Depend. 2008;93(3):233-243.  https://doi.org/10.1016/j.drugalcdep.2007.09.016
  9. Kip MJ, Neumann T, Jugel C, et al. New strategies to detect alcohol use disorders in the preoperative assessment clinic of a German university hospital. Anesthesiology. 2008;109(2):171-179.  https://doi.org/10.1097/ALN.0b013e31817f5be3
  10. Altshuler VB, Chirko VV, Rohlina ML. General psychopathology of narcological diseases. In: Narkologija: nacional’noe rukovodstvo. Pod red. Ivanca N.N., Anohinoj I.P., Vinnikovoj M.A. M.: GEOTAR-Media; 2008. (In Russ.).
  11. Roche AM, Freeman T, Skinner N. From data to evidence, to action: findings from a systematic review of hospital screening studies for high risk alcohol consumption. Drug Alcohol Depend. 2006;83(1):1-14.  https://doi.org/10.1016/j.drugalcdep.2005.10.011
  12. Hecksel KA, Bostwick JM, Jaeger TM, Cha SS. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc. 2008;83(3):274-279.  https://doi.org/10.4065/83.3.274
  13. Makdissi R, Stewart SH. Care for hospitalized patients with unhealthy alcohol use: a narrative review. Addict Sci Clin Pract. 2013;8(1):11. Published 2013 Jun 5.  https://doi.org/10.1186/1940-0640-8-11
  14. Sarff M, Gold JA. Alcohol withdrawal syndromes in the intensive care unit. Crit Care Med. 2010;38(9 suppl):494-501.  https://doi.org/10.1097/CCM.0b013e3181ec5412
  15. National Institute on Alcohol Abuse and Alcoholism: Helping patients who drink too much: A clinician’s guide. US Department of Health and Human Services, 2005.
  16. National Institute on Alcohol Abuse and Alcoholism: Helping patients who drink too much: A clinician’s guide. US Department of Health and Human Services, 2007.
  17. Dawson DA, Grant BF, Li TK. Surgeon General releases advisory on alcohol use in pregnancy (press release). Washington, DC. U.S. Department of Health and Human Services. February 21, 2005. Accessed October 3, 2006. https://www.surgeongeneral.gov/pressreleases/sg02222005.html
  18. Dawson DA, Grant BF, Li TK. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res. 2005;29(5):902-908.  https://doi.org/10.1097/01.alc.0000164544.45746.a7
  19. U.S. Surgeon General releases advisory on alcohol use in pregnancy (press release). Washington, DC. U.S. Department of Health and Human Services. February 21, 2005. Accessed October 3, 2006. https://www.surgeongeneral.gov/pressreleases/sg02222005.html
  20. Brown LA, Cook RT, Jerrells TR, et al. Acute and chronic alcohol abuse modulate immunity. Alcohol Clin Exp Res. 2006;30(9):1624-1631. https://doi.org/10.1111/j.1530-0277.2006.00195.x
  21. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007;31(7):1208-1217. https://doi.org/10.1111/j.1530-0277.2007.00403.x
  22. Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test [published correction appears in J Gen Intern Med. 2010;25(4):375]. J Gen Intern Med. 2009;24(7):783-788.  https://doi.org/10.1007/s11606-009-0928-6
  23. Sørensen LT, Jørgensen T, Kirkeby LT, Skovdal J, Vennits B, Wille-Jørgensen P. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg. 1999;86(7):927-931.  https://doi.org/10.1046/j.1365-2168.1999.01165.x
  24. Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348(18):1786-1795. https://doi.org/10.1056/NEJMra020617
  25. Doering PL, Li R. Substance-related disorders: alcohol, nicotine, and caffeine. In: DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., Posey L. eds. Pharmacotherapy: A Pathophysiologic Approach. 8th ed. New York, NY: McGraw-Hill; 2011:chap 75. Accessed December 22, 2014.
  26. Cravo ML, Glória LM, Selhub J, et al. Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr. 1996;63(2):220-224.  https://doi.org/10.1093/ajcn/63.2.220
  27. Latt N, Dore G. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern Med J. 2014;44(9):911-915.  https://doi.org/10.1111/imj.12522
  28. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA. 1997;278(2):144-151.  https://doi.org/10.1001/jama.278.2.144
  29. Spies CD, Rommelspacher H. Alcohol withdrawal in the surgical patient: prevention and treatment. Anesth Analg. 1999;88(4):946-954.  https://doi.org/10.1097/00000539-199904000-00050
  30. Guthrie SK, Augustin SG. Anxiety disorders. In: Young L.Y., Kradjan W.A., Guglielmo J., Alldredge B.K., Koda-Kimble M.A. (Eds.), Applied Therapeutics: The Clinical Use of Drugs. New York: Wolsters Kluwer and Lippincott Williams & Wilkins; 2008;2137.
  31. Spies C, Tønnesen H, Andreasson S, Helander A, Conigrave K. Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin Exp Res. 2001;25(5 suppl ISBRA):164-170.  https://doi.org/10.1097/00000374-200105051-00028
  32. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353-1357. https://doi.org/10.1111/j.1360-0443.1989.tb00737.x
  33. Spies CD, von Dossow V, Eggers V, et al. Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients. Anesthesiology. 2004;100(5):1088-1100. https://doi.org/10.1097/00000542-200405000-00010
  34. Spies C, Eggers V, Szabo G, et al. Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholics. Am J Respir Crit Care Med. 2006;174(4):408-414.  https://doi.org/10.1164/rccm.200506-907OC
  35. Brunton L, Chabner B, Knollmann B, eds. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011.
  36. «Clinical guidelines for the diagnosis and treatment of alcohol dependence» of the Russian Society of Psychiatrists, 2019 (In Russ.).
  37. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
  38. Schuckit MA. Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med. 2014;371(22):2109-2113. https://doi.org/10.1056/NEJMra1407298
  39. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131(10):1121-1123. https://doi.org/10.1176/ajp.131.10.1121
  40. Fiellin DA, Reid MC, O’Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160(13):1977-1989. https://doi.org/10.1001/archinte.160.13.1977
  41. Choe YM, Lee BC, Choi IG, Suh GH, Lee DY, Kim JW. Combination of the CAGE and serum gamma-glutamyl transferase: an effective screening tool for alcohol use disorder and alcohol dependence. Neuropsychiatr Dis Treat. 2019;15:1507-1515. Published 2019 May 31.  https://doi.org/10.2147/NDT.S203855
  42. Eliasen M, Grønkjær M, Skov-Ettrup LS, et al. Preoperative alcohol consumption and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2013;258(6):930-942.  https://doi.org/10.1097/SLA.0b013e3182988d59
  43. Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome. Am Fam Physician. 2004;69(6):1443-1450.
  44. Muzyk AJ, Kerns S, Brudney S, Gagliardi JP. Dexmedetomidine for the treatment of alcohol withdrawal syndrome: rationale and current status of research. CNS Drugs. 2013;27(11):913-920.  https://doi.org/10.1007/s40263-013-0106-6
  45. Linn DD, Loeser KC. Dexmedetomidine for Alcohol Withdrawal Syndrome. Ann Pharmacother. 2015;49(12):1336-1342. https://doi.org/10.1177/1060028015607038
  46. Awissi DK, Lebrun G, Fagnan M, Skrobik Y; Regroupement de Soins Critiques, Réseau de Soins Respiratoires, Québec. Alcohol, nicotine, and iatrogenic withdrawals in the ICU. Crit Care Med. 2013;41(9 suppl 1):57-68.  https://doi.org/10.1097/CCM.0b013e3182a16919
  47. VanderWeide LA, Foster CJ, MacLaren R, Kiser TH, Fish DN, Mueller SW. Evaluation of Early Dexmedetomidine Addition to the Standard of Care for Severe Alcohol Withdrawal in the ICU: A Retrospective Controlled Cohort Study. J Intensive Care Med. 2016;31(3):198-204.  https://doi.org/10.1177/0885066614554908
  48. Mueller SW, Preslaski CR, Kiser TH, et al. A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med. 2014;42(5):1131-1139. https://doi.org/10.1097/CCM.0000000000000141
  49. Gold JA, Rimal B, Nolan A, Nelson LS. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med. 2007;35(3):724-730.  https://doi.org/10.1097/01.CCM.0000256841.28351.80
  50. Wong A, Benedict NJ, Lohr BR, Pizon AF, Kane-Gill SL. Management of benzodiazepine-resistant alcohol withdrawal across a healthcare system: Benzodiazepine dose-escalation with or without propofol. Drug Alcohol Depend. 2015;154:296-299.  https://doi.org/10.1016/j.drugalcdep.2015.07.005
  51. Pribék IK, Kovács I, Kádár BK, et al. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol — Revised: A systematic review-based meta-analysis. Drug Alcohol Depend. 2021;220:108536. https://doi.org/10.1016/j.drugalcdep.2021.108536
  52. Schmidt KJ, Doshi MR, Holzhausen JM, Natavio A, Cadiz M, Winegardner JE. Treatment of Severe Alcohol Withdrawal. Ann Pharmacother. 2016;50(5):389-401.  https://doi.org/10.1177/1060028016629161
  53. Tonnesen H, Kehlet H. Preoperative alcoholism and postoperative morbidity. Br J Surg. 1999;86(7):869-874.  https://doi.org/10.1046/j.1365-2168.1999.01181.x
  54. Palmer BF, Clegg DJ. Electrolyte Disturbances in Patients with Chronic Alcohol-Use Disorder. N Engl J Med. 2017;377(14):1368-1377. https://doi.org/10.1056/NEJMra1704724
  55. Oppedal K, Møller AM, Pedersen B, Tønnesen H. Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev. 2012;(7):CD008343. Published 2012 Jul 11.  https://doi.org/10.1002/14651858.CD008343.pub2
  56. Solorzano GE, Guha R. Wernicke’s encephalopathy: under our radar more than it should be? Pract Gastroenterol. 2016;40(2):30-36. 
  57. Wrenn KD, Slovis CM, Minion GE, Rutkowski R. The syndrome of alcoholic ketoacidosis. Am J Med. 1991;91(2):119-128.  https://doi.org/10.1016/0002-9343(91)90003-g
  58. Yip L. Ethanol. In: Nelson L., Lewin N., Howland M., Hoffman R., Goldfrank L., Fomenbaum N., eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw-Hill; 2011. Accessed December 18, 2014.
  59. Goodson CM, Clark BJ, Douglas IS. Predictors of severe alcohol withdrawal syndrome: a systematic review and meta-analysis. Alcohol Clin Exp Res. 2014;38(10):2664-2677. https://doi.org/10.1111/acer.12529
  60. Mayo-Smith MF, Bernard D. Late-onset seizures in alcohol withdrawal. Alcohol Clin Exp Res. 1995;19(3):656-659.  https://doi.org/10.1111/j.1530-0277.1995.tb01563.x
  61. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of acute alcohol withdrawal. CMAJ. 1999;160(5):649-655. 
  62. Lejoyeux M, Solomon J, Adès J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol. 1998;33(6):563-575.  https://doi.org/10.1093/alcalc/33.6.563
  63. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010;(3):CD005063. Published 2010 Mar 17.  https://doi.org/10.1002/14651858.CD005063.pub3
  64. Katzung B, Trevor A, eds. Basic and Clinical Pharmacology. 13th ed. New York, NY: McGraw-Hill; 2015.
  65. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002;162(10):1117-1121. https://doi.org/10.1001/archinte.162.10.1117
  66. Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994;272(7):519-523. 
  67. Spies CD, Otter HE, Hüske B, et al. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intensive Care Med. 2003;29(12):2230-2238. https://doi.org/10.1007/s00134-003-2033-3
  68. Jaeger TM, Lohr RH, Pankratz VS. Symptom-triggered therapy for alcohol withdrawal syndrome in medical inpatients. Mayo Clin Proc. 2001;76(7):695-701.  https://doi.org/10.4065/76.7.695
  69. Cassidy EM, O’Sullivan I, Bradshaw P, Islam T, Onovo C. Symptom-triggered benzodiazepine therapy for alcohol withdrawal syndrome in the emergency department: a comparison with the standard fixed dose benzodiazepine regimen. Emerg Med J. 2012;29(10):802-804.  https://doi.org/10.1136/emermed-2011-200509
  70. Holleck JL, Merchant N, Gunderson CG. Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome: a Systematic Review and Meta-analysis of Randomized Controlled Trials. J Gen Intern Med. 2019;34(6):1018-1024. https://doi.org/10.1007/s11606-019-04899-7
  71. Kattimani S, Bharadwaj B. Clinical management of alcohol withdrawal: A systematic review. Ind Psychiatry J. 2013;22(2):100-108.  https://doi.org/10.4103/0972-6748.132914
  72. Foy A, McKay S, Ling S, Bertram M, Sadler C. Clinical use of a shortened alcohol withdrawal scale in a general hospital. Intern Med J. 2006;36(3):150-154.  https://doi.org/10.1111/j.1445-5994.2006.01032.x
  73. Reoux JP, Oreskovich MR. A comparison of two versions of the clinical institute withdrawal assessment for alcohol: the CIWA-Ar and CIWA-AD. Am J Addict. 2006;15(1):85-93.  https://doi.org/10.1080/10550490500419136
  74. Detoxification and substance abuse treatment. In Treatment improvement protocol 45. Edited by Miller N.S., Kipnis S.S. Rockville M.D. Substance Abuse and Mental Health Services Administration. DHHS publication no; 2006;06-4131. https://www.ncbi.nlm.nih.gov/books/NBK64115/pdf/TOC.pdf
  75. Wasilewski D, Matsumoto H, Kur E, et al. Assessment of diazepam loading dose therapy of delirium tremens. Alcohol Alcohol. 1996;31(3):273-278.  https://doi.org/10.1093/oxfordjournals.alcalc.a008147
  76. Hack JB, Hoffmann RS, Nelson LS. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol. 2006;2(2):55-60.  https://doi.org/10.1007/BF03161171
  77. Sohraby R, Attridge RL, Hughes DW. Use of propofol-containing versus benzodiazepine regimens for alcohol withdrawal requiring mechanical ventilation. Ann Pharmacother. 2014;48(4):456-461.  https://doi.org/10.1177/1060028013515846
  78. DeMuro JP, Botros DG, Wirkowski E, Hanna AF. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series. J Anesth. 2012;26(4):601-605.  https://doi.org/10.1007/s00540-012-1381-y
  79. Johnson MT, Yamanaka TT, Fraidenburg DR, Kane SP. Benzodiazepine misadventure in acute alcohol withdrawal: the transition from delirium tremens to ICU delirium. J Anesth. 2013;27(1):135-136.  https://doi.org/10.1007/s00540-012-1458-7
  80. Rosenson J, Clements C, Simon B, et al. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013;44(3):592-598.e2.  https://doi.org/10.1016/j.jemermed.2012.07.056
  81. Oks M, Cleven KL, Healy L, et al. The Safety and Utility of Phenobarbital Use for the Treatment of Severe Alcohol Withdrawal Syndrome in the Medical Intensive Care Unit. J Intensive Care Med. 2020;35(9):844-850.  https://doi.org/10.1177/0885066618783947
  82. Mayo-Smith MF, Beecher LH, Fischer TL, et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline [published correction appears in Arch Intern Med. 2004;164(18):2068. Dosage error in article text]. Arch Intern Med. 2004;164(13):1405-1412. https://doi.org/10.1001/archinte.164.13.1405
  83. Duby JJ, Berry AJ, Ghayyem P, Wilson MD, Cocanour CS. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management. J Trauma Acute Care Surg. 2014;77(6):938-943.  https://doi.org/10.1097/TA.0000000000000352
  84. Brotherton AL, Hamilton EP, Kloss HG, Hammond DA. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature. Pharmacotherapy. 2016;36(4):433-442.  https://doi.org/10.1002/phar.1726
  85. Michaelsen I.H., Anderson J.E., Fink-Jensen A., Allerup P., Ulrichsen J. Phenobarbital versus diazepam for delirium tremens: a retrospective study. Dan Med Bull. 2010; 57:A4169.
  86. Hayner CE, Wuestefeld NL, Bolton PJ. Phenobarbital treatment in a patient with resistant alcohol withdrawal syndrome. Pharmacotherapy. 2009;29(7):875-878.  https://doi.org/10.1592/phco.29.7.875
  87. Hjermø I, Anderson JE, Fink-Jensen A, Allerup P, Ulrichsen J. Phenobarbital versus diazepam for delirium tremens — a retrospective study. Dan Med Bull. 2010;57(8):A4169.
  88. Wong A, Benedict NJ, Kane-Gill SL. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal. J Crit Care. 2015;30(2):405-409.  https://doi.org/10.1016/j.jcrc.2014.10.008
  89. Coomes TR, Smith SW. Successful use of propofol in refractory delirium tremens. Ann Emerg Med. 1997;30(6):825-828.  https://doi.org/10.1016/s0196-0644(97)70059-3
  90. McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med. 2000;28(6):1781-1784. https://doi.org/10.1097/00003246-200006000-00014
  91. Mahajan R, Singh R, Bansal PD, Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens. Ind Psychiatry J. 2010;19(1):58-59.  https://doi.org/10.4103/0972-6748.77641
  92. Hughes DW, Vanwert E, Lepori L, Adams BD. Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient. Am J Emerg Med. 2014;32(1):112.e3-112.e112004. https://doi.org/10.1016/j.ajem.2013.08.044
  93. Lorentzen K, Lauritsen AØ, Bendtsen AO. Use of propofol infusion in alcohol withdrawal-induced refractory delirium tremens. Dan Med J. 2014;61(5):A4807.
  94. Hoffman PL, Grant KA, Snell LD, Reinlib L, Iorio K, Tabakoff B. NMDA receptors: role in ethanol withdrawal seizures. Ann N Y Acad Sci. 1992;654:52-60.  https://doi.org/10.1111/j.1749-6632.1992.tb25955.x
  95. Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004;10(29):3639-3649. https://doi.org/10.2174/1381612043382846
  96. Liang J, Spigelman I, Olsen RW. Tolerance to sedative/hypnotic actions of GABAergic drugs correlates with tolerance to potentiation of extrasynaptic tonic currents of alcohol-dependent rats. J Neurophysiol. 2009;102(1):224-233.  https://doi.org/10.1152/jn.90484.2008
  97. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.  https://doi.org/10.1097/CCM.0b013e3182783b72
  98. Takeshita J. Use of propofol for alcohol withdrawal delirium: a case report. J Clin Psychiatry. 2004;65(1):134-135.  https://doi.org/10.4088/jcp.v65n0122e
  99. Subramaniam K, Gowda RM, Jani K, Zewedie W, Ute R. Propofol combined with lorazepam for severe poly substance misuse and withdrawal states in intensive care unit: a case series and review. Emerg Med J. 2004;21(5):632-634.  https://doi.org/10.1136/emj.2003.007526
  100. Lizotte RJ, Kappes JA, Bartel BJ, Hayes KM, Lesselyoung VL. Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal. Clin Pharmacol. 2014;6:171-177. Published 2014 Oct 31.  https://doi.org/10.2147/CPAA.S70490
  101. Ludtke KA, Stanley KS, Yount NL, Gerkin RD. Retrospective Review of Critically Ill Patients Experiencing Alcohol Withdrawal: Dexmedetomidine Versus Propofol and/or Lorazepam Continuous Infusions. Hosp Pharm. 2015;50(3):208-213.  https://doi.org/10.1310/hpj5003-208
  102. DeCarolis DD, Rice KL, Ho L, Willenbring ML, Cassaro S. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007;27(4):510-518.  https://doi.org/10.1592/phco.27.4.510
  103. Gallimberti L, Canton G, Gentile N, et al. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet. 1989;2(8666):787-789.  https://doi.org/10.1016/s0140-6736(89)90842-8
  104. Leone MA, Vigna-Taglianti F, Avanzi G, Brambilla R, Faggiano F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev. 2010;(2):CD006266. Published 2010 Feb 17.  https://doi.org/10.1002/14651858.CD006266.pub2
  105. Addolorato G, Balducci G, Capristo E, et al. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp Res. 1999;23(10):1596-1604.
  106. Lenzenhuber E, Müller C, Rommelspacher H, Spies C. Gamma-Hydroxybuttersäure zur Therapie des Alkoholentzugssyndroms bei Intensivpatienten. Vergleich zweier symptomorientierter therapeutischer Konzepte [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts]. Anaesthesist. 1999;48(2):89-96.  https://doi.org/10.1007/s001010050672
  107. Elsing C, Stremmel W, Grenda U, Herrmann T. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study. Am J Drug Alcohol Abuse. 2009;35(3):189-192.  https://doi.org/10.1080/00952990902933852
  108. Vagts DA, Iber T, Nöldge-Schomburg GF. Alkohol als perioperatives Problem in Anästhesiologie und Intensivmedizin [Alcohol--a perioperative problem of anaesthesia and intensive care medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2003;38(12):747-761.  https://doi.org/10.1055/s-2003-45400
  109. Leung JG, Hall-Flavin D, Nelson S, Schmidt KA, Schak KM. The role of gabapentin in the management of alcohol withdrawal and dependence. Ann Pharmacother. 2015;49(8):897-906.  https://doi.org/10.1177/1060028015585849
  110. Myrick H, Malcolm R, Randall PK, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009;33(9):1582-1588. https://doi.org/10.1111/j.1530-0277.2009.00986.x
  111. Stock CJ, Carpenter L, Ying J, Greene T. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment. Ann Pharmacother. 2013;47(7-8):961-969.  https://doi.org/10.1345/aph.1R751
  112. Andaluz A, DeMoss D, Claassen C, et al. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study. Am J Drug Alcohol Abuse. 2020;46(1):49-57.  https://doi.org/10.1080/00952990.2019.1634085
  113. Bonnet U, Hamzavi-Abedi R, Specka M, Wiltfang J, Lieb B, Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol Alcohol. 2010;45(2):143-145.  https://doi.org/10.1093/alcalc/agp085
  114. Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP. A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict. 2006;15(1):76-84.  https://doi.org/10.1080/10550490500419110
  115. Levine AR, Carrasquillo L, Mueller J, Nounou MI, Naut ER, Ibrahim D. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis. Pharmacotherapy. 2019;39(9):881-888.  https://doi.org/10.1002/phar.2309
  116. Wilming C, Alford M, Klaus L. Gabapentin Use in Acute Alcohol Withdrawal Management. Fed Pract. 2018;35(3):40-46. 
  117. Nichols TA, Robert S, Taber DJ, Cluver J. Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility. Ment Health Clin. 2019;9(1):1-5. Published 2019 Jan 4.  https://doi.org/10.9740/mhc.2019.01.001
  118. Vadiei N, Smith TL, Walton AE, Kjome KL. Impact of Gabapentin Adjunct use with Benzodiazepines for the Treatment of Alcohol Withdrawal in a Psychiatric Hospital. Psychopharmacol Bull. 2019;49(1):17-27. 
  119. Minozzi S, Amato L, Vecchi S, Davoli M. Anticonvulsants for alcohol withdrawal. Cochrane Database Syst Rev. 2010;(3):CD005064. Published 2010 Mar 17.  https://doi.org/10.1002/14651858.CD005064.pub3
  120. Lai JY, Kalk N, Roberts E. The effectiveness and tolerability of anti-seizure medication in alcohol withdrawal syndrome: a systematic review, meta-analysis and GRADE of the evidence. Addiction. 2022;117(1):5-18.  https://doi.org/10.1111/add.15510
  121. Palestine ML, Alatorre E. Control of acute alcoholic withdrawal symptoms: a comparative study of haloperidol and chlordiazepoxide. Curr Ther Res Clin Exp. 1976;20(3):289-299. 
  122. Crispo AL, Daley MJ, Pepin JL, Harford PH, Brown CV. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines. Pharmacotherapy. 2014;34(9):910-917.  https://doi.org/10.1002/phar.1448
  123. Baddigam K, Russo P, Russo J, Tobias JD. Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med. 2005;20(2):118-123.  https://doi.org/10.1177/0885066604273481
  124. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry. 2006;28(4):362-363.  https://doi.org/10.1016/j.genhosppsych.2006.03.002
  125. Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother. 2008;42(11):1703-1705. https://doi.org/10.1345/aph.1K678
  126. Muzyk AJ, Revollo JY, Rivelli SK. The use of dexmedetomidine in alcohol withdrawal. J Neuropsychiatry Clin Neurosci. 2012;24(3):45-46.  https://doi.org/10.1176/appi.neuropsych.11080194
  127. Tolonen J, Rossinen J, Alho H, Harjola VP. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med. 2013;20(6):425-427.  https://doi.org/10.1097/MEJ.0b013e32835c53b3
  128. Rayner SG, Weinert CR, Peng H, Jepsen S, Broccard AF; Study Institution. Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU. Ann Intensive Care. 2012;2(1):12. Published 2012 May 23.  https://doi.org/10.1186/2110-5820-2-12
  129. Love K, Zimmermann AE. Use of Propofol Plus Dexmedetomidine in Patients Experiencing Severe Alcohol Withdrawal in the Intensive Care Unit. J Clin Pharmacol. 2020;60(4):439-443.  https://doi.org/10.1002/jcph.1539
  130. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489-499.  https://doi.org/10.1001/jama.2009.56
  131. Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial [published correction appears in Crit Care. 2011;15(1):402]. Crit Care. 2010;14(2):R38.  https://doi.org/10.1186/cc8916
  132. Jones GM, Murphy CV, Gerlach AT, Goodman EM, Pell LJ. High-dose dexmedetomidine for sedation in the intensive care unit: an evaluation of clinical efficacy and safety. Ann Pharmacother. 2011;45(6):740-747.  https://doi.org/10.1345/aph.1P726
  133. Zilm DH, Jacob MS, MacLeod SM, Sellers EM, Ti TY. Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcohol Clin Exp Res. 1980;4(4):400-405.  https://doi.org/10.1111/j.1530-0277.1980.tb04839.x
  134. Worner TM. Propranolol versus diazepam in the management of the alcohol withdrawal syndrome: double-blind controlled trial. Am J Drug Alcohol Abuse. 1994;20(1):115-124.  https://doi.org/10.3109/00952999409084061
  135. Weinberg JA, Magnotti LJ, Fischer PE, et al. Comparison of intravenous ethanol versus diazepam for alcohol withdrawal prophylaxis in the trauma ICU: results of a randomized trial. J Trauma. 2008;64(1):99-104.  https://doi.org/10.1097/TA.0b013e31815eb12a
  136. Eggers V, Tio J, Neumann T, et al. Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Intensive Care Med. 2002;28(10):1475-1482. https://doi.org/10.1007/s00134-002-1413-4
  137. Hodges B, Mazur JE. Intravenous ethanol for the treatment of alcohol withdrawal syndrome in critically ill patients. Pharmacotherapy. 2004;24(11):1578-1585. https://doi.org/10.1592/phco.24.16.1578.50945
  138. Egholm JW, Pedersen B, Møller AM, Adami J, Juhl CB, Tønnesen H. Perioperative alcohol cessation intervention for postoperative complications. Cochrane Database Syst Rev. 2018;11(11):CD008343. Published 2018 Nov 8.  https://doi.org/10.1002/14651858.CD008343.pub3
  139. Hansen TB, Bredtoft HK, Larsen K. Preoperative physical optimization in fast-track hip and knee arthroplasty. Dan Med J. 2012;59(2):A4381.
  140. Lowery EM, Yong M, Cohen A, Joyce C, Kovacs EJ. Recent alcohol use prolongs hospital length of stay following lung transplant. Clin Transplant. 2018;32(6):e13250. https://doi.org/10.1111/ctr.13250
  141. Budworth L, Prestwich A, Lawton R, Kotzé A, Kellar I. Preoperative Interventions for Alcohol and Other Recreational Substance Use: A Systematic Review and Meta-Analysis. Front Psychol. 2019;10:34. Published 2019 Feb 4.  https://doi.org/10.3389/fpsyg.2019.00034
  142. Tonnesen H, Rosenberg J, Nielsen HJ, et al. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999;318(7194):1311-1316. https://doi.org/10.1136/bmj.318.7194.1311
  143. Tønnesen H. Alcohol abuse and postoperative morbidity. Dan Med Bull. 2003;50(2):139-160. 
  144. Tønnesen H, Nielsen PR, Lauritzen JB, Møller AM. Smoking and alcohol intervention before surgery: evidence for best practice. Br J Anaesth. 2009;102(3):297-306.  https://doi.org/10.1093/bja/aen401
  145. Tønnesen H. Influence of alcohol on several physiological functions and its reversibility: a surgical view. Acta Psychiatr Scand Suppl. 1992;369:67-71. 
  146. Tønnesen H, Kaiser AH, Nielsen BB, Pedersen AE. Reversibility of alcohol-induced immune depression. Br J Addict. 1992;87(7):1025-1028. https://doi.org/10.1111/j.1360-0443.1992.tb03119.x
  147. Rubinsky AD, Bishop MJ, Maynard C, et al. Postoperative risks associated with alcohol screening depend on documented drinking at the time of surgery. Drug Alcohol Depend. 2013;132(3):521-527.  https://doi.org/10.1016/j.drugalcdep.2013.03.022
  148. Shourie S, Conigrave KM, Proude EM, Ward JE, Wutzke SE, Haber PS. The effectiveness of a tailored intervention for excessive alcohol consumption prior to elective surgery. Alcohol Alcohol. 2006;41(6):643-649.  https://doi.org/10.1093/alcalc/agl059
  149. Kelbaek H, Nielsen BM, Eriksen J, et al. Left ventricular performance in alcoholic patients without chronic liver disease. Br Heart J. 1987;58(4):352-357.  https://doi.org/10.1136/hrt.58.4.352
  150. Ehrenreich H, Schuck J, Stender N, et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res. 1997;21(7):1285-1293.
  151. Coiro V, Casti A, Jotti GS, et al. Adrenocorticotropic hormone/cortisol response to physical exercise in abstinent alcoholic patients. Alcohol Clin Exp Res. 2007;31(5):901-906.  https://doi.org/10.1111/j.1530-0277.2007.00376.x
  152. De Marchi S, Cecchin E, Basile A, Bertotti A, Nardini R, Bartoli E. Renal tubular dysfunction in chronic alcohol abuse — effects of abstinence. N Engl J Med. 1993;329(26):1927-1934. https://doi.org/10.1056/NEJM199312233292605
  153. Fernandez AC, Claborn KR, Borsari B. A systematic review of behavioural interventions to reduce preoperative alcohol use. Drug Alcohol Rev. 2015;34(5):508-520.  https://doi.org/10.1111/dar.12285
  154. Bradley KA, Rubinsky AD, Sun H, et al. Prevalence of alcohol misuse among men and women undergoing major noncardiac surgery in the Veterans Affairs health care system. Surgery. 2012;152(1):69-81.  https://doi.org/10.1016/j.surg.2012.02.007
  155. Felsenfeld AJ, Levine BS. Approach to treatment of hypophosphatemia. Am J Kidney Dis. 2012;60(4):655-661.  https://doi.org/10.1053/j.ajkd.2012.03.024
  156. Kuchly B, Tiksrail A, Baglioni P. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018;378(2):203.  https://doi.org/10.1056/NEJMc1714331
  157. Palmer BF, Clegg DJ. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018;378(2):203-204.  https://doi.org/10.1056/NEJMc1714331
  158. Broeren MA, Geerdink EA, Vader HL, van den Wall Bake AW. Hypomagnesemia induced by several proton-pump inhibitors [published correction appears in Ann Intern Med. 2010;152(4):268]. Ann Intern Med. 2009;151(10):755-756.  https://doi.org/10.7326/0003-4819-151-10-200911170-00016
  159. Park CH, Kim EH, Roh YH, Kim HY, Lee SK. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis. PLoS One. 2014;9(11):e112558. Published 2014 Nov 13.  https://doi.org/10.1371/journal.pone.0112558
  160. Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, et al. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail. 2015;37(7):1237-1241. https://doi.org/10.3109/0886022X.2015.1057800
  161. FDA drug safety communication: low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs). Silver Spring, MD: Food and Drug Administration, March 2, 2011. https://www.fda.gov/drugs/drugsafety/ucm245011.htm
  162. Palmer BF. Diagnostic approach and management of inpatient hyponatremia. J Hosp Med. 2010;5(suppl 3):1-7.  https://doi.org/10.1002/jhm.702
  163. Achinger SG, Ayus JC. Electrolyte Disturbances in Chronic Alcohol-Use Disorder. N Engl J Med. 2018;378(2):202-203.  https://doi.org/10.1056/NEJMc1714331
  164. Sterns RH, Silver SM. Complications and management of hyponatremia. Curr Opin Nephrol Hypertens. 2016;25(2):114-119.  https://doi.org/10.1097/MNH.0000000000000200
  165. Sanghvi SR, Kellerman PS, Nanovic L. Beer potomania: an unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis. 2007;50(4):673-680.  https://doi.org/10.1053/j.ajkd.2007.07.015
  166. Bähr M, Sommer N, Petersen D, Wiethölter H, Dichgans J. Central pontine myelinolysis associated with low potassium levels in alcoholism. J Neurol. 1990;237(4):275-276.  https://doi.org/10.1007/BF00314635
  167. Falcone N, Compagnoni A, Meschini C, Perrone C, Nappo A. Central pontine myelinolysis induced by hypophosphatemia following Wernicke’s encephalopathy. Neurol Sci. 2004;24(6):407-410.  https://doi.org/10.1007/s10072-003-0197-9
  168. Ayus JC, Armstrong D, Arieff AI. Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int. 2006;69(8):1319-1325. https://doi.org/10.1038/sj.ki.5000187
  169. Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med. 2015;372(1):55-65.  https://doi.org/10.1056/NEJMra1404489

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.